within Pharmacolibrary.Drugs.ATC.B;

model B01AD08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 600 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2000000 / 1000000,
    adminCount     = 1,
    Vd             = 0.008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Saruplase is a fibrinolytic (thrombolytic) agent that acts as a plasminogen activator, used for the treatment of acute myocardial infarction and other thromboembolic disorders. It is a recombinant form of urokinase. Saruplase is not widely approved or used in clinical practice today, with most of its development and clinical use occurring in the 1990s.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for intravenous administration in adults with acute myocardial infarction, based on secondary literature and analogy to closely related urokinase-type plasminogen activators. No primary human PK publication is available.</p><h4>References</h4><ol><li><p>Michels, HR, et al., &amp; Bär, FW (1999). Pharmacokinetics and hemostatic effects of saruplase in patients with acute myocardial infarction: comparison of infusion, single-bolus, and split-bolus administration. <i>Journal of thrombosis and thrombolysis</i> 8(3) 213–221. DOI:<a href=&quot;https://doi.org/10.1023/a:1008914321384&quot;>10.1023/a:1008914321384</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10500311/&quot;>https://pubmed.ncbi.nlm.nih.gov/10500311</a></p></li><li><p>van Griensven, JM, et al., &amp; Cohen, AF (1997). Effect of changes in liver blood flow on the pharmacokinetics of saruplase in patients with acute myocardial infarction. <i>Thrombosis and haemostasis</i> 78(3) 1015–1020. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9308746/&quot;>https://pubmed.ncbi.nlm.nih.gov/9308746</a></p></li><li><p>Schneider, J (1993). Fibrin-specific lysis of microthrombosis in endotoxemic rats by saruplase. <i>Thrombosis research</i> 72(1) 71–82. DOI:<a href=&quot;https://doi.org/10.1016/0049-3848(93)90174-m&quot;>10.1016/0049-3848(93)90174-m</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8122189/&quot;>https://pubmed.ncbi.nlm.nih.gov/8122189</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B01AD08;
